Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omnicell (OMCL) Common Equity (2016 - 2026)

Omnicell has reported Common Equity over the past 16 years, most recently at $1.2 billion for Q4 2025.

  • Quarterly Common Equity fell 0.92% to $1.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Dec 2025, down 0.92% year-over-year, with the annual reading at $1.2 billion for FY2025, 0.92% down from the prior year.
  • Common Equity was $1.2 billion for Q4 2025 at Omnicell, up from $1.2 billion in the prior quarter.
  • Over five years, Common Equity peaked at $1.3 billion in Q2 2025 and troughed at $1.0 billion in Q1 2021.
  • The 5-year median for Common Equity is $1.2 billion (2023), against an average of $1.2 billion.
  • Year-over-year, Common Equity grew 21.01% in 2021 and then fell 1.44% in 2022.
  • A 5-year view of Common Equity shows it stood at $1.1 billion in 2021, then dropped by 1.44% to $1.1 billion in 2022, then increased by 5.2% to $1.2 billion in 2023, then increased by 4.57% to $1.2 billion in 2024, then fell by 0.92% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for OMCL's Common Equity are $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.3 billion (Q2 2025).